PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results [Yahoo! Finance]
PURE BIOSCIENCE (PURE)
US:NASDAQ Investor Relations:
purebio.com/investors
Company Research
Source: Yahoo! Finance
non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2025. Summary of Results of Operations – Fiscal First Quarter Net product sales were $707,000 and $555,000 for the fiscal first quarter ended October 31, 2025 and 2024, respectively. The increase of $152,000 was attributable to increased sales across our end-user customer base. Net loss for the fiscal first quarter ended October 31, 2025, was $464,000, compared to $689,000 for the fiscal first quarter ended October 31, 2024. Net loss, excluding share-based compensation, for the fiscal first quarter ended October 31, 2025, was $430,000, compared to $632,000 for the fiscal first quarter ended October 31, 2024. Net loss per share was ($0.00) and ($0.01) for the fiscal first quarter ended October 31, 2025 and 2024, respectively. As an update to the press release dated October 29, 2025, the Company is pleased to report continued momentum acr
Show less
Read more
Impact Snapshot
Event Time:
PURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PURE alerts
High impacting PURE BIOSCIENCE news events
Weekly update
A roundup of the hottest topics
PURE
News
- PURE Bioscience GAAP EPS of $0.00, revenue of $707M [Seeking Alpha]Seeking Alpha
- PURE Bioscience Reports Fiscal First Quarter 2026 Financial ResultsBusiness Wire
- PURE Bioscience, Inc. Announces Leadership Promotions [Yahoo! Finance]Yahoo! Finance
- PURE Bioscience, Inc. Announces Leadership PromotionsBusiness Wire
- PURE Bioscience Reports Fiscal 2025 Financial ResultsBusiness Wire
PURE
Sec Filings
- 12/18/25 - Form PRE
- 12/15/25 - Form 10-Q
- 12/15/25 - Form 8-K
- PURE's page on the SEC website